全文获取类型
收费全文 | 2031篇 |
免费 | 199篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 60篇 |
妇产科学 | 65篇 |
基础医学 | 316篇 |
口腔科学 | 61篇 |
临床医学 | 148篇 |
内科学 | 455篇 |
皮肤病学 | 50篇 |
神经病学 | 200篇 |
特种医学 | 94篇 |
外科学 | 294篇 |
综合类 | 25篇 |
预防医学 | 170篇 |
眼科学 | 28篇 |
药学 | 115篇 |
中国医学 | 8篇 |
肿瘤学 | 115篇 |
出版年
2023年 | 10篇 |
2022年 | 20篇 |
2021年 | 40篇 |
2020年 | 28篇 |
2019年 | 61篇 |
2018年 | 48篇 |
2017年 | 37篇 |
2016年 | 40篇 |
2015年 | 53篇 |
2014年 | 79篇 |
2013年 | 85篇 |
2012年 | 101篇 |
2011年 | 97篇 |
2010年 | 69篇 |
2009年 | 70篇 |
2008年 | 83篇 |
2007年 | 76篇 |
2006年 | 105篇 |
2005年 | 76篇 |
2004年 | 81篇 |
2003年 | 81篇 |
2002年 | 56篇 |
2001年 | 81篇 |
2000年 | 76篇 |
1999年 | 53篇 |
1998年 | 42篇 |
1997年 | 28篇 |
1996年 | 27篇 |
1995年 | 24篇 |
1994年 | 14篇 |
1993年 | 17篇 |
1992年 | 32篇 |
1991年 | 38篇 |
1990年 | 33篇 |
1989年 | 30篇 |
1988年 | 31篇 |
1987年 | 40篇 |
1986年 | 38篇 |
1985年 | 34篇 |
1984年 | 30篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1981年 | 15篇 |
1980年 | 13篇 |
1979年 | 18篇 |
1978年 | 12篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1975年 | 8篇 |
1972年 | 9篇 |
排序方式: 共有2238条查询结果,搜索用时 10 毫秒
91.
92.
93.
Medina A Suarez de Lezo J Pan M Delgado A Segura J Pavlovic D Melián F Romero M Segura F Hernández E Ureña I Herrador J 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2005,32(1):11-15
We analyzed the clinical, angiographic, and late intravascular ultrasonographic findings from 140 patients whose in-stent restenosis was treated with sirolimus-eluting stents. In-stent restenosis remains the main limitation to percutaneous coronary revascularization and has a high recurrence rate after bare stent implantation. From May 2002 through July 2003, we studied 140 patients with clinical restenosis after bare-stent treatment. In 107 patients, in-stent restenosis occurred de novo; in 28 patients, this was the 2nd restenosis; and in another 5, it was the 3rd occurrence. A sirolimus-eluting stent was implanted directly after angiographic evaluation of the in-stent restenosis in 79 patients and after pre-dilation in 61 patients. All patients were given the following antithrombotic regimen: low-molecular-weight heparin, ticlopidine, and aspirin for 1 month, followed by clopidogrel and aspirin for 1 year. Primary success was achieved in 137 patients. Three patients had a non-Q wave myocardial infarction. At the 1-month evaluation, 2 patients had died: 1 due to subacute stent thrombosis and another due to acute mesenteric ischemia. After a mean follow-up of 16 +/- 4 months, the major adverse cardiac events were acute myocardial infarction due to late stent thrombosis in 2 patients and the need for target lesion revascularization in 15 patients. Late angiographic evaluation was performed in 97 patients (69%), 16 of whom had new restenosis: 14 of the restenoses were intrastent, and 2 were at the edges of the stent. Our results suggest that sirolimus-eluting stents are effective in the prevention of in-stent restenosis and, therefore, may become the leading treatment alternative for patients with in-stent restenosis. 相似文献
94.
95.
A. Valdivieso J. Bustamante J.G. Uriarte P. Ruiz I. Pijoan M.J. Suarez J. Ortiz de Urbina 《Transplantation proceedings》2010,42(2):660-662
Management of patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (OLT) is not well established. We conducted a retrospective analysis of our results in the treatment of HCC recurrence after OLT Patients. The 23 HCC recurrences developed after 182 OLT performed for HCC within Milan criteria, had an average follow-up of 60 months.
Results
The median time to recurrence was 23.4 months. Surgical resection of the recurrence was possible in 11 patients, but an R-0 resection was obtained in 8 patients. Four of these 8 patients developed another recurrence, with 3 succumbing due to tumor recurrence and 1 alive at 12 months with recurrence. The other 4 patients without recurrences, include 3 who are alive at 19, 31, and 86 months and 1 who died at 32.6 months due to hepatitis C recurrence. The 3 patients with palliative resections developed recurrences. Twelve patients were rejected for surgery: 8 were treated symptomatically, 2 with systemic chemotherapy, and 2 with everolimus and sorafenib. This last treatment was also prescribed for 2 patients after R-0 surgery who are alive at 19 and 31 months and for 1 patient after R-1 surgery who is alive at 19 months. Of 15 patients who died, 13 succumbed to HCC recurrence. The average survival from transplantation was 61.7 ± 37.5 and 48 ± 34.3 months for patients without and with recurrence, respectively (P < .001). The survival from the recurrence was significantly higher among patients with R-0 surgery: 32.3 ± 21.5 versus 11.9 ± 6.9 months (P = .006).Conclusions
HCC recurrence after OLT of patients within Milan criteria was low but had a great impact on survival. Few cases are amenable to R-0 resection, but when possible it was associated with a significantly increased survival, although with an high incidence of a new recurrence. There is a rationale for the use of sorafenib and mammalian target of rapamycin based immunosuppression, which warrants randomized studies. 相似文献96.
Narjara Gonzalez Suarez Yuniel Fernandez-Marrero Sima Torabidastgerdooei Borhane Annabi 《Nutrients》2022,14(5)
Background: Triple-negative breast cancer (TNBC) cells secretome induces a pro-inflammatory microenvironment within the adipose tissue, which hosts both mature adipocytes and adipose-derived mesenchymal stem/stromal cells (ADMSC). The subsequent acquisition of a cancer-associated adipocyte (CAA)-like phenotype is, however, unknown in ADMSC. While epidemiological studies suggest that consuming a polyphenol-rich diet reduces the incidence of some obesity-related cancers, the chemopreventive impact of green tea-derived epigallocatechin-3-gallate (EGCG) against the cues that trigger the CAA phenotype remain undocumented in ADMSC. Methods: Human ADMSC were exposed to human TNBC-derived MDA-MB-231 conditioned media (TNBC cells secretome) supplemented or not with EGCG. Differential gene expression was assessed through RNA-Seq analysis and confirmed by RT-qPCR. Protein expression levels and the activation status of signal transduction pathways mediators were determined by Western blotting. ADMSC chemotaxis was assessed by a real-time cell migration assay. Results: The TNBC cells secretome induced in ADMSC the expression of the CAA cytokines CCL2, CCL5, IL-1β, and IL-6, and of immunomodulators COX2, HIF-1α, VEGFα, and PD-L1. The epithelial-to-mesenchymal biomarker Snail was found to control the CAA phenotype. EGCG inhibited the induction of CAA genes and the activation status of Smad2 and NF-κB. The induced chemotactic response was also inhibited by EGCG. Conclusion: The induction of an inflammatory and CAA-like phenotype in ADMSC can be triggered by the TNBC cells secretome, while still efficiently prevented by diet-derived polyphenols. 相似文献
97.
Adela Alcolea María Jesús Suarez Manuel Lizasoain Pilar Tejada Fernando Chaves Elia Palenque 《Journal of clinical microbiology》2009,47(9):3043-3044
We report a case of conjunctival tuberculosis in a trainee microbiologist caused by direct inoculation. The resident strain was analyzed by DNA fingerprinting, and an identical pattern was found in an isolate from sputum handled by the resident. After 6 months of treatment, the patient was cured. 相似文献
98.
99.
J. Bergueiro M. Igarzabal J.C. Suarez Sandin H.R. Somacal V. Thatar Vento H. Huck A.A. Valda M. Repetto A.J. Kreiner 《Applied radiation and isotopes》2011,69(12):1676-1679
Several ion sources have been developed and an ion source test stand has been mounted for the first stage of a Tandem-Electrostatic-Quadrupole facility For Accelerator-Based Boron Neutron Capture Therapy. A first source, designed, fabricated and tested is a dual chamber, filament driven and magnetically compressed volume plasma proton ion source. A 4 mA beam has been accelerated and transported into the suppressed Faraday cup. Extensive simulations of the sources have been performed using both 2D and 3D self-consistent codes. 相似文献
100.
A.J. Kreiner W. Castell H. Di Paolo M. Baldo J. Bergueiro A.A. Burlon D. Cartelli V. Thatar Vento J.M. Kesque J. Erhardt J.C. Ilardo A.A. Valda M.E. Debray H.R. Somacal J.C. Suarez Sandin M. Igarzabal H. Huck L. Estrada M. Repetto M. Obligado J. Padulo D.M. Minsky M. Herrera S.J. Gonzalez M.E. Capoulat 《Applied radiation and isotopes》2011,69(12):1672-1675
We describe the present status of an ongoing project to develop a Tandem-ElectroStatic-Quadrupole (TESQ) accelerator facility for Accelerator-Based (AB)-BNCT. The project final goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the 7Li(p,n)7Be reaction. The machine currently being constructed is a folded TESQ with a high-voltage terminal at 0.6 MV. We report here on the progress achieved in a number of different areas. 相似文献